These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17567040)

  • 21. Dilute iron dextran formulation for addition to parenteral nutrient solutions.
    Kwong KW; Tsallas G
    Am J Hosp Pharm; 1980 Feb; 37(2):206-10. PubMed ID: 6767401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of polyethylene glycol on the thermal stability of green fluorescent protein.
    de Lencastre Novaes LC; Mazzola PG; Pessoa A; Penna TC
    Biotechnol Prog; 2010; 26(1):252-6. PubMed ID: 19856402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The difference spectrophotometric assay of 5-hydroxymethylfurfuraldehyde in parenteral formulations of dextrose.
    Davidson AG
    J Clin Pharm Ther; 1987 Feb; 12(1):11-8. PubMed ID: 3449559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the stability and compatibility of drugs in infusion fluids. VI. Factors affecting the stability of ampicillin.
    Stjernström G; Olson OT; Nyqvist H; Lundgren P
    Acta Pharm Suec; 1978; 15(1):33-50. PubMed ID: 25558
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on stability testing in pharmaceutical formulation.
    Lundgren P
    Acta Pharm Suec; 1971 Jun; 8(3):169-92. PubMed ID: 5314840
    [No Abstract]   [Full Text] [Related]  

  • 26. Stability of ondansetron in large-volume parenteral solutions.
    Graham CL; Dukes GE; Kao CF; Bertch JM; Hak LJ
    Ann Pharmacother; 1992 Jun; 26(6):768-71. PubMed ID: 1535245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermal degradation of some parenteral solutions of reserpine. I. Effects of temperature, reserpine concentration, pH and buffer molarity.
    Asker AF; Helal MA; Motawi MM
    Pharmazie; 1973 Aug; 28(8):526-9. PubMed ID: 4784560
    [No Abstract]   [Full Text] [Related]  

  • 28. Metal ion accessibility of histidine-modified superfolder green fluorescent protein expressed in Escherichia coli.
    Tansila N; Becker K; Isarankura Na-Ayudhya C; Prachayasittikul V; Bülow L
    Biotechnol Lett; 2008 Aug; 30(8):1391-6. PubMed ID: 18338218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of light and heat on the stability of montelukast in solution and in its solid state.
    Al Omari MM; Zoubi RM; Hasan EI; Khader TZ; Badwan AA
    J Pharm Biomed Anal; 2007 Nov; 45(3):465-71. PubMed ID: 17719198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of parenteral solutions of cefazolin sodium.
    Bornstein M; Thomas PN; Coleman DL; Boylan JC
    Am J Hosp Pharm; 1974 Mar; 31(3):296-8. PubMed ID: 4206616
    [No Abstract]   [Full Text] [Related]  

  • 31. Investigation of charged polymer influence on green fluorescent protein thermal stability.
    de Lencastre Novaes LC; Mazzola PG; Pessoa A; Vessoni Penna TC
    N Biotechnol; 2011 Jul; 28(4):391-5. PubMed ID: 21334469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo monitoring of intracellular expression of human interleukin-2 using green fluorescent protein fusion partner in Pichia pastoris.
    Cha HJ; Dalal NG; Bentley WE
    Biotechnol Lett; 2004 Jul; 26(14):1157-62. PubMed ID: 15266123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability and compatibility of histamine H2-receptor antagonists in parenteral nutrition mixtures.
    Puzovic M; Hardy G
    Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):311-7. PubMed ID: 17414500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical compatibility and chemical stability of amikacin sulfate in combination with non-antibiotic drugs in large-volume parenteral solutions - part IV.
    Nunning BC; Granatek AP
    Curr Ther Res Clin Exp; 1976 Oct; 20(4):417-91. PubMed ID: 12918
    [No Abstract]   [Full Text] [Related]  

  • 35. Monitoring biosensor capture efficiencies: development of a model using GFP-expressing Escherichia coli O157:H7.
    Simpson-Stroot JM; Kearns EA; Stroot PG; Magaña S; Lim DV
    J Microbiol Methods; 2008 Jan; 72(1):29-37. PubMed ID: 18096260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stability of amino acid infusion solutions. 2. Stability of amino acid mixtures in solution].
    Seydel H; Voigt R
    Pharmazie; 1972 Jul; 27(7):460-6. PubMed ID: 5087243
    [No Abstract]   [Full Text] [Related]  

  • 37. Oxyradical-induced GFP damage and loss of fluorescence.
    Alnuami AA; Zeedi B; Qadri SM; Ashraf SS
    Int J Biol Macromol; 2008 Aug; 43(2):182-6. PubMed ID: 18561996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical compatibility and chemical stability of amikacin sulfate in large-volume parenteral solutions - part II.
    Nunning BC; Granatek AP
    Curr Ther Res Clin Exp; 1976 Oct; 20(4):359-68. PubMed ID: 12917
    [No Abstract]   [Full Text] [Related]  

  • 39. Stability of ricobendazole in aqueous solutions.
    Wu Z; Tucker IG; Razzak M; Medlicott NJ
    J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous intravenous administration of drugs.
    Paris P; Hans P; Lamy M
    Acta Anaesthesiol Belg; 1983 Jun; 34(2):109-15. PubMed ID: 6613510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.